Clinical Trial: A Study to Evaluate the Safety, Tolerability, PK and PD of HNC1058
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: IPF
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Placebo-controlled, Single Ascending Doses (SAD) Study Following Oral Administration in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodyn
Brief Summary:
The purpose of this First-in-Human study is to evaluate the safety and tolerability after single ascending oral doses of HNC1058 given to healthy subjects, compared to placebo.
Read more